Procter & Gamble Health Ltd (PGHL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 346859, "name": "P & G Health Ltd", "stock_name": "P & G Health Ltd", "full_name": "Procter & Gamble Health Ltd", "name_url": "stocks-analysis/p-g-health", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "5,261.00", "chg": 40.75, "chgp": "0.78%", "dir": 1, "prev_price": "5,220.25", "mcapval": "8,753.00 Cr", "mcap": "Small Cap", "scripcode": 500126, "symbol": "PGHL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE199A01012", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "22.75 k", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Procter & Gamble Health Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3811207", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3811207.png", "date": "2026-01-30 10:10:03", "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Procter & Gamble Health Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3794173", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3794173.png", "date": "2026-01-19 10:10:03", "description": "Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Why is Procter & Gamble Health Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-procter-gamble-health-ltd-fallingrising-3790339", "imagepath": "", "date": "2026-01-13 01:05:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Over the past week, Procter & Gamble Health Ltd’s shares have fallen sharply by 6.8%, significantly underperforming the Sensex’s modest 1.83% decline during the same period. This downward momentum has persisted for five consecutive trading sessions, signalling sustained selling pressure. The stock also underperformed its sector by 1.87% on the day, touching an intraday low of ₹5,400, which represents a 3.09% drop from the previous close. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting that sellers dominated the session.</p>\n<p>Technical indicators reinforce this bearish sentiment, with the stock currently trading below all key moving averages, including the..." }, { "title": "Procter & Gamble Health Ltd Falls 2.50%: Mixed Technicals and Valuation Weigh on Stock", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-falls-250-mixed-technicals-and-valuation-weigh-on-stock-3788664", "imagepath": "", "date": "2026-01-11 09:00:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>5 Jan:</strong> Stock opens strong at Rs.5,837.95 (+2.16%) despite Sensex decline</p>\n <p><strong>7 Jan:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>8 Jan:</strong> Downgrade to Sell rating amid mixed technicals and valuation concerns</p>\n <p><strong>9 Jan:</strong> Week closes at Rs.5,571.90 (-2.20%) with continued downward pressure</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,714.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-lab..." }, { "title": "Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-downgraded-to-sell-amid-mixed-technicals-and-valuation-concerns-3785075", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_mojoScore_3785075.png", "date": "2026-01-08 08:08:19", "description": "Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell as of 7 January 2026, driven primarily by a deterioration in technical indicators and valuation metrics. Despite a solid long-term return relative to the Sensex, the company’s flat recent financial performance and expensive valuation have raised concerns among analysts, prompting a reassessment of its investment appeal." }, { "title": "Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-3785070", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_technicaldot_3785070.png", "date": "2026-01-08 08:06:04", "description": "Procter & Gamble Health Ltd (P&G Health) has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as mixed signals emerge from key momentum and trend-following tools." }, { "title": "Procter & Gamble Health Ltd Forms Death Cross, Signalling Potential Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-forms-death-cross-signalling-potential-bearish-trend-3784839", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ProcterGambleHe_dealthcross_3784839.png", "date": "2026-01-07 18:01:19", "description": "Procter & Gamble Health Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector player." }, { "title": "Procter & Gamble Health Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-hold-3773087", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ProcterGambleHe_mojoScore_3773087.png", "date": "2025-12-29 10:10:04", "description": "Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 06 Oct 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "P & G Health Sees Revision in Market Evaluation Amidst Sector Challenges", "link": "https://www.marketsmojo.com/news/stock-recommendation/p-g-health-downgraded-to-hold-by-marketsmojo-amid-valuation-concerns-3762295", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/PGHealth_mojoScore_3762295.png", "date": "2025-12-18 10:10:25", "description": "P & G Health Ltd has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor perception. This adjustment comes amid a backdrop of mixed financial trends and valuation considerations within the Pharmaceuticals & Biotechnology sector." } ], "total": 133, "sid": "346859", "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859" }, "announcements": [ { "caption": "Update on board meeting", "datetime": "21-Jan-2026", "details": "Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Update on board meeting to be held on February 6 2026.", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "16-Jan-2026", "details": "Dear Sir Please find attached compliance certificate under regulation 74(5) of SEBI (DP) Regulations.", "source": "BSE" }, { "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On February 6 2026.", "datetime": "26-Dec-2025", "details": "Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve The meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve unaudited financial results for the quarter ended December 31 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "06 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Procter & Gamble Health Ltd has declared <strong>450%</strong> dividend, ex-date: 22 Aug 25", "dt": "2025-08-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

5 Jan: Stock opens strong at Rs.5,837.95 (+2.16%) despite Sensex decline

7 Jan: Death Cross formation signals potential bearish trend

8 Jan: Downgrade to Sell rating amid mixed technicals and valuation concerns

9 Jan: Week closes at Rs.5,571.90 (-2.20%) with continued downward pressure

Week Open

Rs.5,714.50

Read full news article

Procter & Gamble Health Ltd Downgraded to Sell Amid Mixed Technicals and Valuation Concerns

2026-01-08 08:08:19

Procter & Gamble Health Ltd has seen its investment rating downgraded from Hold to Sell as of 7 January 2026, driven primarily by a deterioration in technical indicators and valuation metrics. Despite a solid long-term return relative to the Sensex, the company’s flat recent financial performance and expensive valuation have raised concerns among analysts, prompting a reassessment of its investment appeal.

Read full news article

Procter & Gamble Health Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-08 08:06:04

Procter & Gamble Health Ltd (P&G Health) has experienced a subtle shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of early January 2026. Despite a strong long-term performance relative to the Sensex, recent technical indicators suggest caution for investors as mixed signals emerge from key momentum and trend-following tools.

Read full news article

Procter & Gamble Health Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-01-07 18:01:19

Procter & Gamble Health Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development suggests a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium-term momentum and raising concerns about long-term weakness in the Pharmaceuticals & Biotechnology sector player.

Read full news article

Procter & Gamble Health Ltd is Rated Hold

2025-12-29 10:10:04

Procter & Gamble Health Ltd is rated Hold by MarketsMOJO, with this rating last updated on 06 Oct 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

P & G Health Sees Revision in Market Evaluation Amidst Sector Challenges

2025-12-18 10:10:25

P & G Health Ltd has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor perception. This adjustment comes amid a backdrop of mixed financial trends and valuation considerations within the Pharmaceuticals & Biotechnology sector.

Read full news article